Effect of a Cepham Supplement on Hot Flashes and Menopausal Symptoms in Postmenopausal Women

NANot yet recruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

August 30, 2025

Study Completion Date

September 30, 2025

Conditions
D008593
Interventions
DIETARY_SUPPLEMENT

Shatavari Root Extract, oral capsule

"This intervention consists of a proprietary, standardized extract of Asparagus racemosus (Shatavari), formulated specifically for women's health and cognitive support. The supplement is provided in oral capsule form and standardized to a specific concentration of shatavarin IV, the primary active compound. Participants will take one capsule daily for 30 days.~This formulation, known as SheVari4™, is patent-pending and manufactured by Cepham, designed to address vasomotor symptoms (hot flashes) and other menopausal concerns. It is distinct from other Shatavari supplements in its standardization and use in a placebo-controlled, double-blind trial targeting postmenopausal women."

Trial Locations (1)

32211

Jacksonville University, Jacksonville

All Listed Sponsors
lead

Jacksonville University

OTHER

NCT06939868 - Effect of a Cepham Supplement on Hot Flashes and Menopausal Symptoms in Postmenopausal Women | Biotech Hunter | Biotech Hunter